Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Maria Giovanna di Bari"'
Autor:
James L. Gulley, Chiara Intrivici, Matteo Vergati, Jeffrey Schlom, Caroline Jochems, Ngar-Yee Huen, Kwong Y. Tsang, David Apelian, Vittore Cereda, Maria Giovanna di Bari
Publikováno v:
Vaccine. 29:4992-4999
We compared the effects of yeast-treated human dendritic cells (DCs) with CD40L-matured human DCs for the induction of effector cells and the number and functionality of CD4 + CD25 + CD127 − FoxP3 + regulatory T cells (Tregs). DCs were treated with
Autor:
Helen Sabzevari, Benedetto Farsaci, Jack P. Higgins, Shinji Takai, Maria Giovanna di Bari, Jeffrey Schlom, James W. Hodge
Publikováno v:
International Journal of Cancer. 127:1603-1613
Small molecule BCL-2 inhibitors are being examined as monotherapy in phase I/II clinical trials for several types of tumors. However, few data are available about the effect of BCL-2 inhibitors on immune function. The aims of our study were to invest
Autor:
Helen Sabzevari, Maria Giovanna di Bari, M. E. Christine Lutsiak, Shinji Takai, Sven Mostböck, Jeffrey Schlom, Benedetto Farsaci, Lalage M. Wakefield, Roshanak Tolouei Semnani
Publikováno v:
Cancer Immunology, Immunotherapy. 58:1809-1818
This study demonstrates that CD8+ T cells in the tumor microenvironment display reduced functionality and hyporesponsiveness. TGF-beta contributed markedly to the tumor-infiltrating CD8+ T cells' (TILs) reduced functionality, which could be reversed
Autor:
Vincenzo Formica, Renee N. Donahue, Jeffrey Schlom, Vittore Cereda, Benedetto Farsaci, Fiorella Guadagni, Mario Roselli, Maria Giovanna di Bari, James L. Gulley, Caroline Jochems, Antonella Spila
Publikováno v:
Oncoimmunology
Several lines of investigation have revealed the apparent interplay between the immune system of the host and many conventional, "standard-of-care" anticancer therapies, including chemotherapy and small molecule targeted therapeutics. In particular,
Autor:
Venturina Stagni, Roberto Testi, Yaniv Lerenthal, Maria Teresa Cencioni, Silvia Cursi, Maria Giovanna di Bari, Daniela Barilà, Enrico Cundari, Ivano Condò
Publikováno v:
Blood (2007).
info:cnr-pdr/source/autori:Stagni V, di Bari MG, Cursi S, Condo I, Cencioni MT, Testi R, Lerenthal Y, Cundari E, Barila D./titolo:ATM kinase activity modulates Fas sensitivity through the regulation of FLIP in lymphoid cells./doi:/rivista:Blood/anno:2007/pagina_da:/pagina_a:/intervallo_pagine:/volume
Blood 111 (2008): 829–837.
info:cnr-pdr/source/autori:Stagni V, di Bari MG, Cursi S, Condò I, Cencioni MT, Testi R, Lerenthal Y, Cundari E, Barilà D./titolo:ATM kinase activity modulates Fas sensitivity through the regulation of FLIP in lymphoid cells./doi:/rivista:Blood/anno:2008/pagina_da:829/pagina_a:837/intervallo_pagine:829–837/volume:111
info:cnr-pdr/source/autori:Stagni V, di Bari MG, Cursi S, Condo I, Cencioni MT, Testi R, Lerenthal Y, Cundari E, Barila D./titolo:ATM kinase activity modulates Fas sensitivity through the regulation of FLIP in lymphoid cells./doi:/rivista:Blood/anno:2007/pagina_da:/pagina_a:/intervallo_pagine:/volume
Blood 111 (2008): 829–837.
info:cnr-pdr/source/autori:Stagni V, di Bari MG, Cursi S, Condò I, Cencioni MT, Testi R, Lerenthal Y, Cundari E, Barilà D./titolo:ATM kinase activity modulates Fas sensitivity through the regulation of FLIP in lymphoid cells./doi:/rivista:Blood/anno:2008/pagina_da:829/pagina_a:837/intervallo_pagine:829–837/volume:111
Ataxia telangiectasia (A-T) is a rare cancer-predisposing genetic disease, caused by the lack of functional ATM kinase, a major actor of the double strand brakes (DSB) DNA-damage response. A-T patients show a broad and diverse phenotype, which includ
Autor:
Maria Giovanna di Bari, Silvia Soddu, Daniela Barilà, Roberto Testi, Michele Mingardi, Laura Ciuffini
Publikováno v:
EMBO reports. 7(7)
c-Abl function is strictly dependent on its subcellular localization. Using an in vitro approach, we identify c-Abl as a new substrate for p300, CBP (CREB-binding protein) and PCAF (p300/CBP-associated factor) histone acetyltransferases. Remarkably,
Autor:
Matteo Vergati, Jeffrey Schlom, Maria Giovanna di Bari, James L. Gulley, Vittore Cereda, Caroline Jochems, Ngar-Yee Huen, Kwong Y. Tsang, C. Intrivici, David Apelian
Publikováno v:
Cancer Research. 71:758-758
Regulatory T cells (Tregs) have been broadly related to modulation of the antitumor immune response. We have previously shown that whole, heat-killed, recombinant Saccharomyces cerevisiae yeast genetically modified to express carcinoembryonic antigen
Autor:
James L. Gulley, Ngar-Yee Huen, Jeffrey Schlom, Maria Giovanna di Bari, Matteo Vergati, Vittore Cereda, Kwong Y. Tsang, Alex Franzusoff
Publikováno v:
Cancer Research. 70:2405-2405
It has been demonstrated that recombinant Saccharomyces cerevisiae yeast vector containing the transgene encoding carcinoembryonic antigen (yeast-CEA) activates human dendritic cells (DCs) and stimulates CEA-specific T-cell responses. Numerous studie